Immune cell showdown: autoimmune vs. infection vs. healthy
NCT ID NCT02422875
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at immune cells from people with autoimmune diseases (like lupus), people with infections, and healthy volunteers. Researchers want to understand how these cells differ and what makes them attack the body in autoimmune conditions. The study involves blood and bone marrow samples but does not test any new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,500 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Aug 2012
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
* Subjects with certain autoimmune conditions or if subjects have brothers, sisters, mother, father, or children with an autoimmune condition * Subjects with certain infectious diseases * Subjects who are without an autoimmune condition or infectious disease * Subjects who have received or will receive a vaccination as part of their regular standard of care from one of their healthcare providers
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Signed written informed consent by the subject or, if the subject is unable to provide informed consent, the subject's legal representative may provide consent. * Subjects can be of either gender * Subjects with autoimmune diseases, and Systemic Lupus Erythematosus (SLE) patients will fulfill the American College of Rheumatology Classification criteria for SLE to be determined by their treating physician but may have incomplete criteria (\<4 items). SLE patients are not restricted by treatment or by disease activity as determined by Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or Systemic Lupus Activity Measure (SLAM) score 1. Subjects with acute exacerbations of their disease, including hospitalized patients 2. First-degree relatives of subjects with active disease * Subjects who have received or will receive a vaccination may be enrolled for bone marrow aspirates before and/or after vaccination. Vaccination will have been done by the subject's healthcare provider or through another outside source. * Subjects may have a screening blood draw performed in cases where a certain subset of cells or antibody titer is desired. This may be followed by additional blood draws and/or bone marrow aspiration after the ideal candidates have been identified. * Subjects who have been diagnosed with HIV or another infectious disease * Subjects taking biologic and/or immune modulatory agents in diseases such as cancer, allergy, and pulmonary diseases will be enrolled. * Healthy controls must be free of acute or chronic disease at the time of bone marrow donation. Healthy controls that are first-degree relatives of subjects with active disease will be enrolled as well. Exclusion Criteria: * Poor venous access * Subjects who have had side effects to local anesthetics such as lidocaine and who are on blood thinners such as warfarin * Normal controls must be free of acute or chronic diseases or medications that may affect the assay (as determined by the investigator). * For subjects donating bone marrow, insufficient access to the iliac crest such that the periosteum and bone is hindered based on normal aspiration procedures. * Pregnant or lactating women may not donate bone marrow.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Autoimmune diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Emory University Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Grady Health System
Atlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 'Queen Mothers' bring HIV testing to the doorstep?
- 150,000 children to be tracked from birth to old age in massive health study
- Scientists map HIV's hiding spots in early infection
- Can a Blood-Cleaning device hit its plasma exchange targets?
- Can local clinics keep more people with HIV in care?
- Can a phone call keep HIV-Positive mothers and babies on track?